Patents Assigned to CYSBIO APS
  • Patent number: 11555212
    Abstract: The present invention generally relates to the field of biotechnology as it applies to the production of aryl sulfates using recombinant host cells. More particularly, the present invention pertains to recombinant host cells comprising (e.g., expressing) a polypeptide having aryl sulfotransferase activity, wherein said recombinant host cells have been modified to have an increased uptake of sulfate compared to identical host cells that does not carry said modification. Further provided are processes for the production of aryl sulfates, such as zosteric acid, employing such recombinant host cells.
    Type: Grant
    Filed: January 27, 2021
    Date of Patent: January 17, 2023
    Assignee: CysBio ApS
    Inventors: Christian Bille Jendresen, Alex Toftgaard Nielsen
  • Patent number: 11407976
    Abstract: The present invention generally relates to the microbiological industry, and specifically to the production of L-serine or L-serine derivatives using genetically modified bacteria. The present invention provides genetically modified microorganisms, such as bacteria, wherein the expression of genes encoding for enzymes involved in the degradation of L-serine is attenuated, such as by inactivation, which makes them particularly suitable for the production of L-serine at higher yield. The present invention also provides means by which the microorganism, and more particularly a bacterium, can be made tolerant towards higher concentrations of serine. The present invention also provides methods for the production of L-serine or L-serine derivative using such genetically modified microorganisms.
    Type: Grant
    Filed: October 6, 2020
    Date of Patent: August 9, 2022
    Assignee: CysBio ApS
    Inventors: Hemanshu Mundhada, Alex Toftgaard Nielsen
  • Patent number: 11390894
    Abstract: The present invention generally relates to the field of biotechnology as it applies to the production of aryl sulfates using polypeptides or recombinant cells comprising said polypeptides. More particularly, the present invention pertains to polypeptides having aryl sulfotransferase activity, recombinant host cells expressing same and processes for the production of aryl sulfates employing these polypeptides or recombinant host cells.
    Type: Grant
    Filed: July 30, 2020
    Date of Patent: July 19, 2022
    Assignee: CysBio ApS
    Inventors: Christian Bille Jendresen, Alex Toftgaard Nielsen
  • Patent number: 11306331
    Abstract: The present invention generally relates to the field of biotechnology as it applies to the production of hydroxycinnamic acids using polypeptides having tyrosine ammonia lyase activity. More particularly, the present invention pertains to polypeptides having tyrosine ammonia lyase activity and high substrate specificity towards tyrosine, which makes them particularly suitable in the production of p-coumaric acid and other hydroxycinnamic acids. The present invention thus provides processes for the production of p-coumaric acid and other hydroxycinnamic acids employing these polypeptides as well as recombinant host cells expressing same.
    Type: Grant
    Filed: July 24, 2020
    Date of Patent: April 19, 2022
    Assignee: CYSBIO APS
    Inventors: Christian Bille Jendresen, Solvej Siedler, Steen Gustav Stahlhut, Alex Toftgaard Nielsen
  • Patent number: 10954536
    Abstract: The present invention generally relates to the field of biotechnology as it applies to the production of aryl sulfates using recombinant host cells. More particularly, the present invention pertains to recombinant host cells comprising (e.g., expressing) a polypeptide having aryl sulfotransferase activity, wherein said recombinant host cells have been modified to have an increased uptake of sulfate compared to identical host cells that does not carry said modification. Further provided are processes for the production of aryl sulfates, such as zosteric acid, employing such recombinant host cells.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: March 23, 2021
    Assignee: CysBio ApS
    Inventors: Christian Bille Jendresen, Alex Toftgaard Nielsen
  • Patent number: 10793826
    Abstract: The present invention generally relates to the microbiological industry, and specifically to the production of L-serine or L-serine derivatives using genetically modified bacteria. The present invention provides genetically modified microorganisms, such as bacteria, wherein the expression of genes encoding for enzymes involved in the degradation of L-serine is attenuated, such as by inactivation, which makes them particularly suitable for the production of L-serine at higher yield. The present invention also provides means by which the microorganism, and more particularly a bacterium, can be made tolerant towards higher concentrations of serine. The present invention also provides methods for the production of L-serine or L-serine derivative using such genetically modified microorganisms.
    Type: Grant
    Filed: January 27, 2016
    Date of Patent: October 6, 2020
    Assignee: CysBio Aps
    Inventors: Hemanshu Mundhada, Alex Toftgaard Nielsen
  • Patent number: 10752923
    Abstract: The present invention generally relates to the field of biotechnology as it applies to the production of hydroxycinnamic acids using polypeptides having tyrosine ammonia lyase activity. More particularly, the present invention pertains to polypeptides having tyrosine ammonia lyase activity and high substrate specificity towards tyrosine, which makes them particularly suitable in the production of p-coumaric acid and other hydroxycinnamic acids. The present invention thus provides processes for the production of p-coumaric acid and other hydroxycinnamic acids employing these polypeptides as well as recombinant host cells expressing same.
    Type: Grant
    Filed: July 14, 2015
    Date of Patent: August 25, 2020
    Assignee: CYSBIO APS
    Inventors: Christian Bille Jendresen, Solvej Siedler, Steen Gustav Stahlhut, Alex Toftgaard Nielsen
  • Patent number: 10590440
    Abstract: The present invention relates to the production of hydrolyzates from a lignocellulose-containing material, and to fermentation of the hydrolyzates. More specifically, the present invention relates to the detoxification of phenolic inhibitors and toxins formed during the processing of lignocellulose-containing material by enzymatically sulfating the phenolic inhibitors and toxins using aryl sulfotranseferases.
    Type: Grant
    Filed: August 21, 2015
    Date of Patent: March 17, 2020
    Assignee: CysBio ApS
    Inventors: Christian Bille Jendresen, Alex Toftgaard Nielsen
  • Patent number: 10513682
    Abstract: The present invention generally relates to the microbiological industry, and specifically to the production of L-serine using genetically modified bacteria. The present invention provides genetically modified microorganisms, such as bacteria, wherein the expression of genes encoding for enzymes involved in the degradation of L-serine is attenuated, such as by inactivation, which makes them particularly suitable for the production of L-serine at higher yield. The present invention also provides means by which the microorganism, and more particularly a bacterium, can be made tolerant towards higher concentrations of serine. The present invention also provides methods for the production of L-serine or L-serine derivative using such genetically modified microorganisms.
    Type: Grant
    Filed: January 27, 2016
    Date of Patent: December 24, 2019
    Assignee: CYSBIO APS
    Inventors: Hemanshu Mundhada, Alex Toftgaard Nielsen